Medical Laboratories & Research Industry

Below are the top small-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of return on investment. The trailing-twelve-month return on investment at Biocept (NASDAQ: BIOC) is 156.90%. Biocept's revenue for the same period is $0.10 million. The trailing-twelve-month...

Below are the top medical laboratories & research stocks on the NYSE in terms of dividend yield. Quest Diagnostics (NYSE: DGX) has a dividend yield of 2.20%. Quest Diagnostics' shares closed at $63.21 on Friday. Agilent Technologies (NYSE: A) has a dividend yield of 0.90%. Agilent's shares...

Below are the top medical laboratories & research stocks on the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Psychemedics (NASDAQ: PMD) is 14.50%. Psychemedics' EPS for the same period is $0.72. The trailing-twelve-month profit margin at Bio-Reference...

Below are the top mid-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of PEG ratio. Quest Diagnostics (NYSE: DGX) has a PEG ratio of 1.13. Quest's trailing-twelve-month revenue is $7.20 billion. Laboratory Corp. of America Holdings (NYSE: LH) has a PEG ratio of...

Below are the top mid-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Laboratory Corp. of America Holdings (NYSE: LH) is 10.00%. Laboratory Corp had $185.80 million in total cash for the latest quarter...

Below are the top small-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of revenue estimate for the current year. Analysts expect Alere (NYSE: ALR) to post revenue of $2.78 billion for the year ending December, 2012. Alere had $303.15 million in total cash for...

Below are the top mid-cap medical laboratories & research stocks on the NYSE and the NASDAQ: in terms of PEG ratio. Laboratory Corp. of America Holdings (NYSE: LH) has a PEG ratio of 1.05. Laboratory Corp's trailing-twelve-month revenue is $5.63 billion. Quest Diagnostics (NYSE: DGX) has a...

Below are the top mid-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of return on assets. The trailing-twelve-month return on assets at Laboratory Corp. of America Holdings (NYSE: LH) is 10.96%. Laboratory Corp. of America's operating margin for the same period...

Below are the top mid-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of cash. Life Technologies Corporation (NASDAQ: LIFE) had $865.32 million in total cash and $2.75 billion in total debt for the latest quarter. Covance Inc (NYSE: CVD) had $389.10 million in...

Below are the top mid-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Laboratory Corp of America Holdings (NYSE: LH) is 24.61%. LH's PEG ratio is 1.24. The trailing-twelve-month return on equity...

Below are the top mid-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year. The earnings estimate for Laboratory Corp of America Holdings (NYSE: LH) for the next year ending December, 2012 is $7.14 per share. LH's trailing-twelve...

Below are the top mid-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at Laboratory Corp. of America Holdings (NYSE: LH) is 20.02%. LH's ROE for the same period is 24.61%. The trailing-twelve-month...

Below are the top mid-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of cash. Quest Diagnostics Incorporated (NYSE: DGX) had $994.20 million in total cash and $4.22 billion in total debt for the latest quarter. Pharmaceutical Product Development Inc (NASDAQ:...

Below are the top small-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year. The earnings estimate for ICON plc (NASDAQ: ICLR) for the next year ending December, 2012 is $1.54 per share. ICLR's trailing-twelve-month ROE is 14.02...

Below are the top small-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of revenue. The trailing-twelve-month revenue at PAREXEL International Corporation (NASDAQ: PRXL) is $1.40 billion. PRXL's ROE for the same period is 12.58%. The trailing-twelve-month...